Company / Assets per Share
Ernexa Therapeutics Inc. Assets per Share History
FY2014-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Assets per Share
$1.70
FY2025
5-year range
$0.97 / $9.58
FY2021-FY2025
Trend
+74.8%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Assets per Share has fluctuated over the past 10 years, ranging from $0.18 in FY2015 to $9.58 in FY2023.
Based on SEC 10-K filings.
1.70 in FY2025 with a 10-year CAGR of +25.4%.
Declined from $9.58 to $1.70 over the past 2 years.
Assets per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- +5.7%
- 10-Year CAGR
- +25.4%
Key checks
Key Insights
- In FY2025, assets per share increased 74.8% year-over-year.
- Peak assets per share was recorded in FY2023.
- Lowest assets per share in the period was in FY2015.
Company context
Key Data Points
- Altman Z-Score -8.07 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.70 | +74.8% |
| FY2024 | $0.97 | -89.8% |
| FY2023 | $9.58 | +642.3% |
| FY2020 | $1.29 | -73.7% |
| FY2019 | $4.91 | -16.7% |
| FY2018 | $5.90 | +3189.2% |
| FY2017 | $0.18 | -98.0% |
| FY2016 | $9.03 | +4983.1% |
| FY2015 | $0.18 | -37.3% |
| FY2014 | $0.28 | +30.3% |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026